Search results for "From ACP Internist Weekly"


 
Results 51 - 60 of about 60 for "From ACP Internist Weekly".

October 10, 2014 | ACP Diabetes Monthly

ACP Diabetes Monthly delivers a monthly summary of news about diabetes, including the latest research, clinical guidelines, and FDA drug actions.

Weight loss, improvement in comorbid conditions after laparoscopic sleeve gastrectomy appear to decline with time, study finds | ACP Diabetes Monthly

Bariatric surgery with laparoscopic sleeve gastrectomy (LSG) improves weight loss and comorbid conditions related to obesity in the short term, but its effects decline over the long term, according to a new study.

Troponin concentration may help stratify risk in those with stable ischemic heart disease and diabetes | ACP Diabetes Monthly

Researchers used a high-sensitivity assay to measure cardiac troponin T concentration at baseline, then analyzed whether it was associated with a composite end point (death from cardiovascular causes, myocardial infarction, or stroke).

January 12, 2018 | ACP Diabetes Monthly

ACP Diabetes Monthly delivers a monthly summary of news about diabetes, including the latest research, clinical guidelines, and FDA drug actions.

Study suggests less frequent retinopathy screening in low-risk patients with type 1 diabetes | ACP Diabetes Monthly

Researchers modeled the effects of individualizing screening based on current retinal status and mean glycated hemoglobin level, finding that the overall number of exams could be reduced.

July 13, 2018 | ACP Diabetes Monthly

ACP Diabetes Monthly delivers a monthly summary of news about diabetes, including the latest research, clinical guidelines, and FDA drug actions.

No clear-cut choice among once-weekly GLP-1 receptor agonists | ACP Diabetes Monthly

All once-weekly GLP-1 receptor agonists reduced HbA1c and fasting plasma glucose levels, and either no differences or clinically marginal differences were found among the drugs for blood pressure, blood lipid levels, and C-reactive protein levels,

ACE inhibitors, ARBs most effective against ESRD in patients with diabetes, kidney disease | ACP Diabetes Monthly

Angiotensin-converting enzyme (ACE) inhibitors and angiotensin-receptor blockers (ARBs) appear most effective in preventing end-stage renal disease (ESRD) in patients with diabetes and kidney disease, although no regimen to lower blood pressure

Exercise tips for type 1 diabetes offered by consensus statement | ACP Diabetes Monthly

The consensus statement advises physicians about ways to manage people with type 1 diabetes who exercise regularly, including glucose targets for safe and effective exercise and nutritional and insulin dose adjustments to protect against

Gastric bypass benefits persist over long-term follow-up, study finds | ACP Diabetes Monthly

At 12 years, patients who underwent Roux-en-Y gastric bypass had significantly greater weight loss and lower risk of diabetes than those who didn't receive surgery.

Result Page: Prev   1   2   3   4   5   6   Next